Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Weissbrich

Showing results (11-20 of 31) with videos related to

Pageof 4
Sort By:
AIDS Research and Human Retroviruses|May 26, 2001
Characterization of HIV-specific proliferative T cell responses in HIV-infected personsY Zhang, M Huber, B Weissbrich, et al.
Annals of Hematology|July 3, 1999
Prevention of hepatitis B flare-up during chemotherapy using lamivudine: case report and review of the literatureO H Al-Taie, H Mörk, A M Gassel, et al.
Gut|December 15, 2007
Therapy of interferon-induced depression in chronic hepatitis C with citalopram: a randomised, double-blind, placebo-controlled studyM R Kraus, A Schäfer, K Schöttker, et al.
European Journal of Medical Research|March 18, 2000
Therapeutic drug monitoring of saquinavir in patients during protease inhibitor therapy with saquinavir alone or in combination with ritonavir or nelfinavirP Langmann, M Zilly, B Weissbrich, et al.
European Journal of Medical Research|August 15, 2002
Efavirenz plasma levels for the prediction of treatment failure in heavily pretreated HIV-1 infected patientsP Langmann, B Weissbrich, S Desch, et al.
Infection|August 5, 2004
Lipid lowering therapy with fluvastatin and pravastatin in patients with HIV infection and antiretroviral therapy: comparison of efficacy and interaction with indinavirA Benesic, M Zilly, F Kluge, et al.
European Journal of Medical Research|January 9, 2004
No influence of the P-glycoprotein genotype (MDR1 C3435T) on plasma levels of lopinavir and efavirenz during antiretroviral treatmentRalf Winzer, P Langmann, M Zilly, et al.
Neuropediatrics|April 21, 2001
Fulminant course in a case of diffuse myelinoclastic encephalitis-- a case reportM Poppe, W Brück, G Hahn, et al.
Annals of Neurology|February 5, 1998
Isolation and characterization of an oligodendrocyte precursor-derived B-cell epitope in multiple sclerosisJ J Archelos, J Trotter, S Previtali, et al.
European Journal of Medical Research|November 15, 2008
Low trough levels of tipranavir in a combination antiretroviral therapy of tipranavir/ritonavir and tenofovir require therapeutic drug monitoringP Langmann, R Winzer, D Schirmer, et al.
Pageof 4

Showing results (11-20 of 31) with videos related to

Sort By:
Pageof 4
AIDS Research and Human Retroviruses|May 26, 2001
Characterization of HIV-specific proliferative T cell responses in HIV-infected personsY Zhang, M Huber, B Weissbrich, et al.
Annals of Hematology|July 3, 1999
Prevention of hepatitis B flare-up during chemotherapy using lamivudine: case report and review of the literatureO H Al-Taie, H Mörk, A M Gassel, et al.
Gut|December 15, 2007
Therapy of interferon-induced depression in chronic hepatitis C with citalopram: a randomised, double-blind, placebo-controlled studyM R Kraus, A Schäfer, K Schöttker, et al.
European Journal of Medical Research|March 18, 2000
Therapeutic drug monitoring of saquinavir in patients during protease inhibitor therapy with saquinavir alone or in combination with ritonavir or nelfinavirP Langmann, M Zilly, B Weissbrich, et al.
European Journal of Medical Research|August 15, 2002
Efavirenz plasma levels for the prediction of treatment failure in heavily pretreated HIV-1 infected patientsP Langmann, B Weissbrich, S Desch, et al.
Infection|August 5, 2004
Lipid lowering therapy with fluvastatin and pravastatin in patients with HIV infection and antiretroviral therapy: comparison of efficacy and interaction with indinavirA Benesic, M Zilly, F Kluge, et al.
European Journal of Medical Research|January 9, 2004
No influence of the P-glycoprotein genotype (MDR1 C3435T) on plasma levels of lopinavir and efavirenz during antiretroviral treatmentRalf Winzer, P Langmann, M Zilly, et al.
Neuropediatrics|April 21, 2001
Fulminant course in a case of diffuse myelinoclastic encephalitis-- a case reportM Poppe, W Brück, G Hahn, et al.
Annals of Neurology|February 5, 1998
Isolation and characterization of an oligodendrocyte precursor-derived B-cell epitope in multiple sclerosisJ J Archelos, J Trotter, S Previtali, et al.
European Journal of Medical Research|November 15, 2008
Low trough levels of tipranavir in a combination antiretroviral therapy of tipranavir/ritonavir and tenofovir require therapeutic drug monitoringP Langmann, R Winzer, D Schirmer, et al.
Pageof 4